Back to Authors

Bender, Steven D.

https://orcid.org/0000-0002-5454-464X

Mayo Clinic

Baylor University

Citations 2

Trigger Point Injections for Headache Disorders: Expert Consensus Methodology and Narrative Review
Kuruvilla, Deena E. , Blumenfeld, Andrew , Sorrell, Michael R., Robertson, Carrie E. , Grosberg, Brian M. , Bender, Steven D. , Napchan, Uri, Robbins, Matthew S. , Charleston, Larry , Ashkenazi, Avi , Robertson, Carrie E

Headache: The Journal of Head and Face Pain | August 28, 2014 | Volume: 54 | Issue: 9 | Pages: 1441-1459

10.1111/head.12442 Get It

Objective/Background To review the existing literature and describe a standardized methodology by expert consensus for the performance of trigger point injections ( TPIs ) in the treatment of headache disorders. Despite their widespread use, the efficacy, safety, and methodology of TPIs have not been reviewed specifically for headache disorders by expert consensus. Methods The Peripheral Nerve Blocks and Other Interventional Procedures Special Interest Section of the A merican H eadache S ociety over a series of meetings reached a consensus for nomenclature, indications, contraindications, precautions, procedural details, outcomes, and adverse effects for the use of TPIs for headache disorders. A subcommittee of the Section also reviewed the literature. Results Indications for TPIs may include many types of episodic and chronic primary and secondary headache disorders, with the presence of active trigger points ( TPs ) on physical examination. Contraindications may include infection, a local open skull defect, or an anesthetic allergy, and precautions are necessary in the setting of anticoagulant use, pregnancy, and obesity with unclear anatomical landmarks. The most common muscles selected for TPIs include the trapezius, sternocleidomastoid, and temporalis, with bupivacaine and lidocaine the agents used most frequently. Adverse effects are typically mild with careful patient and procedural selection, though pneumothorax and other serious adverse events have been infrequently reported. Conclusions When performed in the appropriate setting and with the proper expertise, TPIs seem to have a role in the adjunctive treatment of the most common headache disorders. We hope our effort to characterize the methodology of TPIs by expert opinion in the context of published data motivates the performance of evidence‐based and standardized treatment protocols.
Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches – A Narrative Review
Blumenfeld, Andrew , Napchan, Uri, Bender, Steven D. , Klein, Brad , Berliner, Randall, Schim, Jack , Friedman, Deborah I. , Young, William B. , Robertson, Carrie E. , Silberstein, Stephen D., Ashkenazi, Avi , Ailani, Jessica , Charleston, Larry , Dodick, David W. , Robbins, Matthew S. , Robertson, Carrie E , Friedman, Deborah I , Klein, Brad C

Headache: The Journal of Head and Face Pain | February 13, 2013 | Volume: 53 | Issue: 3 | Pages: 437-446

10.1111/head.12053 Get It

Objective To describe a standardized methodology for the performance of peripheral nerve blocks ( PNB s) in the treatment of headache disorders. Background PNBs have long been employed in the management of headache disorders, but a wide variety of techniques are utilized in literature reports and clinical practice. Methods The A merican H eadache S ociety S pecial I nterest S ection for PNBs and other I nterventional P rocedures convened meetings during 2010‐2011 featuring formal discussions and agreements about the procedural details for occipital and trigeminal PNBs . A subcommittee then generated a narrative review detailing the methodology. Results PNB indications may include select primary headache disorders, secondary headache disorders, and cranial neuralgias. Special procedural considerations may be necessary in certain patient populations, including pregnancy, the elderly, anesthetic allergy, prior vasovagal attacks, an open skull defect, antiplatelet/anticoagulant use, and cosmetic concerns. PNBs described include greater occipital, lesser occipital, supratrochlear, supraorbital, and auriculotemporal injections. Technical success of the PNB should result in cutaneous anesthesia. Targeted clinical outcomes depend on the indication, and include relief of an acute headache attack, terminating a headache cycle, and transitioning out of a medication‐overuse pattern. Reinjection frequency is variable, depending on the indications and agents used, and the addition of corticosteroids may be most appropriate when treating cluster headache. Conclusions These recommendations from the A merican H eadache S ociety S pecial I nterest S ection for PNBs and other I nterventional P rocedures members for PNB methodology in headache disorder treatment are derived from the available literature and expert consensus. With the exception of cluster headache, there is a paucity of evidence, and further research may result in the revision of these recommendations to improve the outcome and safety of these interventions.